NIMBEX Drug Patent Profile
✉ Email this page to a colleague
When do Nimbex patents expire, and what generic alternatives are available?
Nimbex is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in NIMBEX is cisatracurium besylate. There are nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nimbex
A generic version of NIMBEX was approved as cisatracurium besylate by SANDOZ INC on February 3rd, 2012.
Summary for NIMBEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 63 |
Clinical Trials: | 13 |
Patent Applications: | 696 |
Drug Prices: | Drug price information for NIMBEX |
What excipients (inactive ingredients) are in NIMBEX? | NIMBEX excipients list |
DailyMed Link: | NIMBEX at DailyMed |
Recent Clinical Trials for NIMBEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mahidol University | Phase 4 |
Makassed General Hospital | N/A |
Assiut University | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for NIMBEX
US Patents and Regulatory Information for NIMBEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551-001 | Dec 15, 1995 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | NIMBEX PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 020551-003 | Dec 15, 1995 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abbvie | NIMBEX PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 020551-002 | Dec 15, 1995 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NIMBEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551-001 | Dec 15, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Abbvie | NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551-001 | Dec 15, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NIMBEX
See the table below for patents covering NIMBEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 1003407 | AGENTS DE BLOCAGE NEUROMUSCULAIRE. | ⤷ Try a Trial |
France | 2665701 | AGENTS DE BLOCAGE NEUROMUSCULAIRE. | ⤷ Try a Trial |
Italy | 8048000 | ⤷ Try a Trial | |
South Korea | 0174284 | ⤷ Try a Trial | |
Hong Kong | 80196 | Neuromuscular blocking agents | ⤷ Try a Trial |
Canada | 2087104 | INHIBITEUR NEUROMUSCULAIRE (NEUROMUSCULAR BLOCKING AGENTS) | ⤷ Try a Trial |
Hungary | T67613 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |